MEGHAN GARABEDIAN: Open Payments
NPI 1023497377 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,641 in 16 payments from 2 companies in 2025. Trend: 2023 $6,331 · 2024 $462 · 2025 $9,641
Consulting: $7,560Travel & lodging: $1,450Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $5,229 |
| Genentech USA, Inc. | 8 | $4,411 |
Products named: KESIMPTA, Ocrevus.
Industry payments across PA — which companies pay providers there.
